Loading organizations...
Loading organizations...
Biotechnology company developing non-toxic cancer therapies.
Onchilles Pharma has raised $32.0M across 2 funding rounds.
Onchilles Pharma has raised $32.0M in total across 2 funding rounds.
Onchilles Pharma has raised $32.0M in total across 2 funding rounds.
Onchilles Pharma's investors include InVivium Capital, Kennedy Lewis Investment Management, Lincoln Park Capital, LYZZ Capital, University of Chicago Medicine, Court R. Turner, University of Chicago.
Onchilles Pharma has raised $32.0M across 2 funding rounds. Most recently, it raised $25.0M Series A in November 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 7, 2025 | $25.0M Series A | InVivium Capital, Kennedy Lewis Investment Management, Lincoln Park Capital, LYZZ Capital, University of Chicago Medicine | |
| Jun 10, 2021 | $7.0M Series A | Court R. Turner | University of Chicago |